menu search

ENZ / Why Is Enzo Biochem (ENZ) Stock Up 72% Today?

Why Is Enzo Biochem (ENZ) Stock Up 72% Today?
Enzo Biochem (NYSE: ENZ ) stock is rocketing higher on Friday after the company agreed to an asset sale with Labcorp (NYSE: LH ). That asset sale has Enzo Biochem agreeing to divest its Clinical Laboratory division to Labcorp. Read More
Posted: Mar 17 2023, 07:46
Author Name: InvestorPlace
Views: 102893

ENZ News  

Enzo Biochem: Cleaned Up And Cash-Rich But Unloved

By Seeking Alpha
October 26, 2023

Enzo Biochem: Cleaned Up And Cash-Rich But Unloved

Enzo Biochem is a microcap company with a $30 million revenue run-rate Life Sciences business and $78-$85 million in cash. The company is likely being more_horizontal

Why Is Enzo Biochem (ENZ) Stock Up 72% Today?

By InvestorPlace
March 17, 2023

Why Is Enzo Biochem (ENZ) Stock Up 72% Today?

Enzo Biochem (NYSE: ENZ ) stock is rocketing higher on Friday after the company agreed to an asset sale with Labcorp (NYSE: LH ). That asset sale has more_horizontal

Enzo Biochem, Inc. (ENZ) Q1 2023 Earnings Call Transcript

By Seeking Alpha
December 13, 2022

Enzo Biochem, Inc. (ENZ) Q1 2023 Earnings Call Transcript

Enzo Biochem, Inc. (NYSE:ENZ ) Q1 2023 Earnings Conference Call December 13, 2022 8:30 AM ET Company Participants Unidentified Company Representative more_horizontal

Enzo Biochem, Inc. Announces Date of Annual Shareholders' Meeting

By GlobeNewsWire
November 8, 2022

Enzo Biochem, Inc. Announces Date of Annual Shareholders' Meeting

NEW YORK, NY, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostic more_horizontal

Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th

By GlobeNewsWire
June 2, 2022

Enzo Biochem, Inc. (ENZ) CEO Hamid Erfanian on Q2 2022 Results - Earnings Call Transcript

By Seeking Alpha
March 14, 2022

Enzo Biochem, Inc. (ENZ) CEO Hamid Erfanian on Q2 2022 Results - Earnings Call Transcript

Enzo Biochem, Inc. (ENZ) CEO Hamid Erfanian on Q2 2022 Results - Earnings Call Transcript more_horizontal

Enzo Biochem to Present at the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum

By GlobeNewsWire
March 10, 2022

Enzo Biochem to Present at the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum

NEW YORK, NY, March 10, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ), a leading biosciences and diagnostics company, today announced that m more_horizontal

Enzo Biochem to Report Second Quarter 2022 Financial Results and Business Update on Monday, March 14th

By GlobeNewsWire
March 8, 2022


Search within

Pages Search Results: